Alex Slater

Alex Slater is the Head of the Global Business Development team at Crown Bioscience, having joined the business in 2021 after working at several different CROs that supported all phases of drug discovery and development.

Throughout his twenty-seven-year career in business development, Alex has worked with large CROs, such as Covance (LabCorp Drug Development), where he supported Europe and Asia Pacific business development teams selling central laboratory services in support of clinical trials. Alex has also led global business development teams at Eurofins Discovery and served as the VP of Business Development and GM of Europe for Science Exchange, a Silicon Valley start-up.

Alex holds a BSc degree in Medical Biochemistry from the University of Surrey.